IRON vs IEP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IRON · Disc Medicine$78.91 ▲ 0.56%
IEP · Icahn Enterprises$4.75 ▼ 7.41%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IRON -5.6%
- IEP -31.9%
Head to head
| Metric | IRON | IEP |
|---|---|---|
| Price | $78.91 | $4.75 |
| Change today | ▲ 0.56% | ▼ 7.41% |
| Market cap | $3.59B | $3.60B |
| Return, 3 months | +0.8% | -31.5% |
| Return, year to date | -0.6% | -23.4% |
| Return, 1 year | -5.9% | -30.7% |
| P/E (TTM) | – | – |
| P/B | 5.9 | 4.8 |
| P/E percentile vs own 5y | 49th | 76th |
| Dividend yield | – | 42.11% |
| Revenue growth (YoY, latest qtr) | – | +40.6% |
| Net profit growth (YoY) | -7.8% | -93.0% |
| Gross margin | – | 14.0% |
| Operating margin | – | 0.5% |
| Net margin | – | -4.9% |
| Return on equity | -39.1% | -37.4% |
| Analyst target vs. price | +56.4% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 57 | 15 |
| 30-day volatility | 105.5% | 36.1% |
| Max drawdown, 1 year | -40.8% | -35.1% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IEP is the largest of the group by market value.
- IRON has returned the most over the past year.
- IEP has been the calmest stock over the last 30 days.